Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type Versus Mutated Proteins
ISRN Oncology
doi 10.1155/2013/536529
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Hindawi Limited